Page last updated: 2024-09-03

omega-n-methylarginine and Hyperlipoproteinemia Type II

omega-n-methylarginine has been researched along with Hyperlipoproteinemia Type II in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Bruin, TW; Koomans, HA; Rabelink, TJ; Stroes, ES1
Kastelein, JJ; Koomans, HA; Milstien, S; Rabelink, TJ; van Loon, D; Verhaar, MC; Wever, RM1

Trials

1 trial(s) available for omega-n-methylarginine and Hyperlipoproteinemia Type II

ArticleYear
Effects of oral folic acid supplementation on endothelial function in familial hypercholesterolemia. A randomized placebo-controlled trial.
    Circulation, 1999, Jul-27, Volume: 100, Issue:4

    Topics: Administration, Oral; Adult; Blood Vessels; Cross-Over Studies; Double-Blind Method; Endothelium, Vascular; Enzyme Inhibitors; Female; Folic Acid; Forearm; Hematinics; Humans; Hyperlipoproteinemia Type II; Male; omega-N-Methylarginine; Prospective Studies; Regional Blood Flow; Vasoconstriction; Vasodilation

1999

Other Studies

1 other study(ies) available for omega-n-methylarginine and Hyperlipoproteinemia Type II

ArticleYear
Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication.
    Lancet (London, England), 1995, Aug-19, Volume: 346, Issue:8973

    Topics: Adult; Arginine; Blood Pressure; Cholesterol; Cholestyramine Resin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Forearm; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Infusions, Intravenous; Lovastatin; Male; Nitroprusside; omega-N-Methylarginine; Regional Blood Flow; Serotonin; Simvastatin; Vasodilation

1995